Opioid Use
Research Study

Researchers at Yale University are conducting a study to better understand how cannabinoid type 1 (CB1) receptors function in people with opioid use disorder (OUD). By comparing brain imaging results from people with OUD who are receiving or starting buprenorphine treatment with those of healthy volunteers, researchers hope to learn more about the role of the endocannabinoid system and its potential to support future OUD treatments.

Fast Facts

Seeking treatment
for opioid use

Ages 25-65

Compensation
up to $1,200

Conducted in
Connecticut

Additional Information

Researchers want to understand whether CB1 receptor availability differs in people with opioid use disorder compared with healthy individuals. The findings may help researchers explore new approaches to treating OUD by targeting the endocannabinoid system.

You may be eligible for this study if you meet the following criteria.

  • Ages 25-65
  • Interested in starting treatment for opioid use
  • Willing to start buprenorphine or have already started it within the past 2 weeks
  • No current or past diagnosis of a serious psychiatric disorder, such as schizophrenia or bipolar disorder, or current diagnosis of PTSD
  • Do not currently use SSRIs
  • Have not used benzodiazepines within the past 30 days

If you are interested in participating, you will first complete a phone interview to determine whether you may qualify. If eligible, study participation may include the following:

  1. Screening: Researchers will review your medical history and eligibility. You must be between 25 and 65 years old and, if you have OUD, be actively seeking treatment and willing to start buprenorphine or have started it within the past two weeks.
  2. Health assessments: You may complete psychiatric evaluations, a physical examination, an electrocardiogram (ECG), and blood tests.
  3. Brain imaging: You will undergo an anatomical magnetic resonance imaging (MRI) scan and one positron emission tomography (PET) scan to help researchers study CB1 receptors. A catheter may be inserted into an artery in your wrist during the PET scan to collect blood samples.
  4. Study completion: Your participation will help researchers compare CB1 receptor availability in people with OUD and healthy volunteers. Bloodwork is available at no cost, and results are provided to participants.

Participants can receive up to $1,200 for taking part in the study. Bloodwork is provided at no cost, and results are available to participants.

There is no cost for you to participate in our research study.